F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. Woronoff et al., Cancer incidence and mortality in France over the 1980???2012 period: Solid tumors, Revue d'??pid??miologie et de Sant?? Publique, vol.62, issue.2, pp.95-108, 2014.
DOI : 10.1016/j.respe.2013.11.073

N. Leone, N. Voirin, L. Roche, F. Binder-foucard, A. Woronoff et al., Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015, 2015.

C. Allemani, H. Weir, H. Carreira, R. Harewood, D. Spika et al., Global surveillance of cancer survival 1995???2009: analysis of individual data for 25???676???887 patients from 279 population-based registries in 67 countries (CONCORD-2), The Lancet, vol.385, issue.9972, pp.977-1010, 2015.
DOI : 10.1016/S0140-6736(14)62038-9

D. Angelis, R. Sant, M. Coleman, M. Francisci, S. Baili et al., Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014.
DOI : 10.1016/S1470-2045(13)70546-1

B. Fowble, L. Solin, D. Schultz, and R. Goodman, Ten year results of conservative surgery and irradiation for stage I and II breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.269-77, 1991.
DOI : 10.1016/0360-3016(91)90771-U

R. Tomin and W. Donegan, Screening for recurrent breast cancer--its effectiveness and prognostic value., Journal of Clinical Oncology, vol.5, issue.1, pp.62-69, 1987.
DOI : 10.1200/JCO.1987.5.1.62

J. Grünfeld and . Rapport-au-président-de-la-république, Recommandations pour le Plan Cancer Pour un nouvel élan, 2009.

. France and . Loi, portant réforme de l'hôpital et relative aux patients, à la santé et aux territoires, 2009.

J. Vernant, Recommandations pour le troisième plan cancer, 2013.

C. Erikson, E. Salsberg, G. Forte, S. Bruinooge, and M. Goldstein, Future Supply and Demand for Oncologists : Challenges to Assuring Access to Oncology Services, Journal of Oncology Practice, vol.3, issue.2, pp.79-86, 2007.
DOI : 10.1200/JOP.0723601

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793740

L. Lichtenfeld, Cancer Care and Survivorship Planning: Promises and Challenges, Journal of Oncology Practice, vol.5, issue.3, pp.116-124, 2009.
DOI : 10.1200/JOP.0934407

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790677/pdf

C. Roorda, A. Berendsen, M. Haverkamp, K. Meer, . Van-der et al., Discharge of breast cancer patients to primary care at the end of hospital follow-up: A cross-sectional survey, European Journal of Cancer, vol.49, issue.8, pp.1836-1880, 2013.
DOI : 10.1016/j.ejca.2013.01.016

M. Nissen, M. Beran, M. Lee, S. Mehta, D. Pine et al., Views of primary care providers on follow-up care of cancer patients, Fam Med, vol.39, pp.477-82, 2007.

A. Dawes, M. Hemmelgarn, D. Nguyen, G. Sacks, S. Clayton et al., Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer. 15 avr 2015, pp.1249-56

C. Allemani, P. Minicozzi, F. Berrino, E. Bastiaannet, A. Gavin et al., Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002, International Journal of Cancer, vol.106, issue.Suppl. 6, pp.2404-2416, 2000.
DOI : 10.1002/ijc.11226

J. Khatcheressian, P. Hurley, E. Bantug, L. Esserman, E. Grunfeld et al., Breast Cancer Follow-Up and Management After Primary Treatment, Clinical Oncology Clinical Practice Guideline Update. JCO. 1 mars, vol.31, issue.7, pp.961-966, 2013.

E. Grunfeld, Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update), Canadian Medical Association Journal, vol.172, issue.10, pp.1319-1339, 2005.
DOI : 10.1503/cmaj.045062

E. Senkus, S. Kyriakides, S. Ohno, F. Penault-llorca, P. Poortmans et al., Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.26, issue.suppl 5, pp.8-30, 2015.
DOI : 10.1093/annonc/mdv298

B. Cutuli, L. Arnould, and B. Barreau, Recommandations pour la prise en charge des carcinomes canalaires in situ du sein. Institut National Contre le Cancer, pp.9-20, 2009.

M. Rojas, E. Telaro, A. Russo, I. Moschetti, L. Coe et al., Follow-up strategies for women treated for early breast cancer, Cochrane Database Syst Rev, vol.4, issue.4, p.1768, 2005.
DOI : 10.1007/BF01806043

URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001768.pub2/pdf/abstract

D. Montgomery, K. Krupa, and W. Jack, Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience, British Journal of Cancer, vol.2, issue.12, pp.1802-1809, 2007.
DOI : 10.1016/0360-3016(89)90003-5

C. Chargari, Y. Kirova, and M. Bollet, Shared responsibility for follow-up of breast cancer patients. Experience of the Institut Curie, Bull Cancer, vol.95, pp.1047-51, 2008.

E. Grunfeld, D. Mant, M. Vessey, and R. Fitzpatrick, Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract, pp.60-65, 1995.

E. Grunfeld, D. Mant, and P. Yudkin, Routine follow up of breast cancer in primary care: randomised trial, BMJ, vol.313, issue.7058, pp.665-674, 1996.
DOI : 10.1136/bmj.313.7058.665

J. Khatcheressian and T. Smith, Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care, Journal of Clinical Oncology, vol.24, issue.6, pp.835-842, 2006.
DOI : 10.1200/JCO.2005.04.5153

E. Grunfeld, R. Fitzpatrick, and D. Mant, Comparison of breast cancer patient satisfaction with follow-up in primary care vs specialist care: results from a randomized controled trial, Br J Clin Pract, vol.49, pp.705-715, 1996.

A. Fourcade, S. Houzard, C. Dubot, A. Fourquet, S. Fridmann et al., Breast cancer followup by primary care physician: patient satisfaction in the Metropolitan Paris region], Bull Cancer, vol.99, issue.10, pp.915-940, 2012.

S. Smith, S. Murchison, S. Singh-carlson, C. Alexander, and E. Wai, Survivorship care in breast cancer, Les soins aux survivantes du cancer du sein, Canadian Family Physician. 1 juin, vol.61, issue.6, pp.277-83, 2015.

C. Roorda, G. De-bock, C. Scholing, K. Van-der-meer, M. Berger et al., Patients' preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study, Health Expectations, vol.12, issue.Suppl. 2, pp.2192-201, 2015.
DOI : 10.1080/13645570701606028

URL : http://onlinelibrary.wiley.com/doi/10.1111/hex.12189/pdf

I. Chait, R. Glynne-jones, and S. Thomas, A pilot study exploring the effect of discharging cancer survivors from hospital follow-up on the workload of general practitioners, Br J Gen Pract J R Coll Gen Pract, vol.48, issue.430, pp.1241-1244, 1998.

H. Bouysie, Etude sur le suivi par les médecins généralistes des femmes traitées pour un cancer du sein. Enquête auprès de 282 médecins généralistes d'Aquitaine. Doctorat de médecine générale, Bordeaux: université Bordeaux, vol.2, 2015.

C. Farquhar, E. Kofa, and J. Slutsky, Clinicians' attitudes to clinical practice guidelines : a systematic review-attitudes-clinical-practice-guidelines-systematic- review, Disponible sur, 2002.

T. Maurina, L. Chaigneau, F. Bazan, C. Villanueva, A. Thiery-vuillemin et al., Follow-up in patients with early breast cancer, Bull Cancer. oct, vol.98, issue.9, pp.1091-106, 2011.

I. Curie, Infos cancer du sein, Disponible sur, 2017.

. Réseau-de-cancérologie-d-'aquitaine, La surveillance du cancer du sein. [en ligne]. [consulté le 28 Disponible sur : http://www.canceraquitaine.org/sites/default/files/documents/INFOS- PRO/surveillance-sein, 2017.

L. Ligue-contre-le-cancer, Le cancer du sein. [en ligne]. [consulté le 28 Disponible sur : https://www.ligue-cancer, 2017.

A. Fondation and . La-recherche-sur-le-cancer, Les cancers du sein. [en ligne]. [consulté le 28, Disponible sur, 2017.

E. France, Après cancer. [en ligne]. [consulté le 28, Disponible sur, 2017.

L. Thomas, N. Cullum, and E. Mccoll, Guidelines in professions allied to medicine, Cochrane Review, vol.1, issue.2, 2002.
DOI : 10.7326/0003-4819-100-1-130

A. Audet, S. Greenfield, and M. Field, Medical Practice Guidelines: Current Activities and Future Directions, Annals of Internal Medicine, vol.113, issue.9, pp.709-714, 1990.
DOI : 10.7326/0003-4819-113-9-709

S. Zwolsman, E. Te-pas, L. Hooft, M. Wieringa-de-waard, and N. Van-dijk, Barriers to GPs' use of evidence-based medicine: a systematic review, British Journal of General Practice, vol.62, issue.600, pp.511-532, 2012.
DOI : 10.3399/bjgp12X652382

B. Carlsen, C. Glenton, and C. Pope, Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines, British Journal of General Practice, vol.57, issue.545, pp.971-979, 2007.
DOI : 10.3399/096016407782604820

M. Luctkar-flude, A. Aiken, M. Mccoll, and J. Tranmer, A comprehensive framework and key guideline recommendations for the provision of evidence-based breast cancer survivorship care within the primary care setting, Family Practice, vol.32, issue.2, pp.129-169, 2015.
DOI : 10.1093/fampra/cmu082

P. Bouet, J. Rault, L. Breton-lerouvillois, and G. , Atlas de la démographie médicale en France, 2015.

D. Dershaw, B. Mccormick, and M. Osborne, Detection of local recurrence after conservative therapy for breast carcinoma.Cancer, pp.493-499, 1992.

B. Fowble, L. Solin, D. Schultz, J. Rubenstein, and R. Goodman, Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment, International Journal of Radiation Oncology*Biology*Physics, vol.19, issue.4, pp.833-875, 1990.
DOI : 10.1016/0360-3016(90)90002-2

J. R. Kurtz, H. Brandone, Y. Ayme, J. Jacquemier, J. Pietra et al., Amalric Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis.Cancer, pp.1912-1919, 1989.

E. Molina-montes, M. Requena, E. Sánchez-cantalejo, M. Fernández, M. Arroyo-morales et al., Risk of second cancers cancer after a first primary breast cancer: A systematic review and meta-analysis, Gynecologic Oncology, vol.136, issue.1, pp.2015158-71
DOI : 10.1016/j.ygyno.2014.10.029

B. Haffty, C. Lee, L. Philpotts, L. Horvath, B. Ward et al., Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients, Cancer J Sci Am, vol.4, pp.35-40, 1998.

T. Givioinvestigators, Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial, JAMA, vol.271, pp.1587-92, 1994.

C. Davies, H. Pan, and J. Godwin, Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2013.
DOI : 10.1016/S0140-6736(12)61963-1

C. Early-breast, . Trialists-'collaborative, . Group, . Ebctcg-), R. Peto et al., Comparisons between different polychemotherapy regimens for early breast cancer : metaanalyses of long-term outcome among 100,000 women in 123 randomised trials, Lancet. 2012 Feb, vol.4379, issue.9814, pp.432-476

H. Burstein, S. Temin, and H. Anderson, Adjuvant Endocrine Therapy for Women With Hormone Receptor???Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update, Journal of Clinical Oncology, vol.32, issue.21, pp.2255-69, 2014.
DOI : 10.1200/JCO.2013.54.2258

R. Grol and J. Grimshaw, From best evidence to best practice: effective implementation of change in patients' care, The Lancet, vol.362, issue.9391, pp.1225-1255, 2003.
DOI : 10.1016/S0140-6736(03)14546-1

E. Grecop, Changing Physicians' Practices, New England Journal of Medicine, vol.329, issue.17, pp.1271-1275, 1993.
DOI : 10.1056/NEJM199310213291714

J. Grimshaw, R. Thomas, and G. Maclennan, Effectiveness and efficiency of guideline dissemination and implementation strategies, Health Technol Assess, vol.8, pp.1-72, 2004.

P. Durieux, P. Ravaud, P. Dosquet, and A. Durocher, Effectiveness of clinical guideline implementation strategies : systematic review of systematic reviews, Gastroenterol Clin Biol. nov, vol.24, issue.11, pp.1018-1043, 2000.

J. Bachimont, J. Cogneau, and A. Letourmy, Pourquoi les médecins généralistes n'observent-ils pas les recommandations de bonnes pratiques cliniques ? L'exemple du diabète de type 2, Sciences sociales et santé. 1 juin, vol.24, issue.2, pp.75-103, 2006.
DOI : 10.3406/sosan.2006.1681

URL : http://www.persee.fr/docAsPDF/sosan_0294-0337_2006_num_24_2_1681.pdf

. Aidéa-(-www, aidea-ligue.net) Conseils juridiques et accompagnement pour le droit à l'emprunt, pp.111-101

. Lieux-d-'accompagnement, information : Espaces Cancer Info Centre d'oncologie et de radiothérapie du Pays Basque -Service de radiothérapie 14 allées Paulmy -64100 Bayonne Tél, pp.5-59

E. Chu-de-bordeaux-hôpital and . Saint, André : lundi, mardi 10h-17h Pellegrin -Centre FX Michelet : mercredi 9h-13h Pellegrin -Tripode : mercredi 14h-16h Maison du Haut- Lévêque : jeudi 10h-17h, vendredi 9h-16h Tél. : 05 57 82 01 97, mail : eri@chubordeaux.fr ? Institut Bergonié : 229 cours de l'Argonne -33076 Bordeaux Cedex Tél, 05 56 33 33 54, mail : l.innocenti@bordeaux.unicancer.fr Kiosques d'Information sur le Cancer (KIC) ? Maison du Bien-Être -Centre de santé du Pavillon de la Mutualité 45 cours Galliéni - 33000 Bordeaux Tél. : 06 67 60 92 22, mail : instantdebeaute@hotmail.fr ? Maison de la Ligue Bayonne Espace Rive Gauche -66 allées Marines -64100, pp.5-59

S. Arimidex and . Femara, AROMASINE) prévoir une ostéodensitométrie à l'initiation du traitement, à renouveler tous les 2 ans si elle est altérée après avoir débuté un traitement

. Si-un-traitement-par, Herceptine est administré (tumeur Her2+; 10 % des cas) une surveillance de la fonction cardiaque tous les 3 mois est alors nécessaire le temps du traitement ( = 1 an

S. Il-y-a-eu-chirurgie-avec-curage-axillaire, il existe un risque de lymphoedème du bras qui nécessite quelques précautions : pas de prise de tension ou de prise de sang du côté opéré

S. Il-y-a-eu-chimiothérapie, on peut noter : -des troubles cognitifs fréquents (trouble de mémoire) qui régresseront dans l'année qui suit le traitement

. La-survenue-d, un épisode dépressif réactionnel est fréquent surtout à 2-3 mois de la fin de la radiothérapie. Si des anti dépresseurs sont nécessaires on rappelle que la fluoxétine (PROZAC) ou la paroxétine (DEROXAT)